L. Kappos Et Al. , "The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study," 60th Annual Meeting of the American-Academy-of-Neurology , vol.70, Illinois, United States Of America, 2008
Kappos, L. Et Al. 2008. The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study. 60th Annual Meeting of the American-Academy-of-Neurology , (Illinois, United States Of America).
Kappos, L., Miller, D., MacManus, D., Gold, R., Havrdova, E., Limmroth, V., ... Polman, C.(2008). The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study . 60th Annual Meeting of the American-Academy-of-Neurology, Illinois, United States Of America
Kappos, Ludwig Et Al. "The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study," 60th Annual Meeting of the American-Academy-of-Neurology, Illinois, United States Of America, 2008
Kappos, Ludwig Et Al. "The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study." 60th Annual Meeting of the American-Academy-of-Neurology , Illinois, United States Of America, 2008
Kappos, L. Et Al. (2008) . "The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study." 60th Annual Meeting of the American-Academy-of-Neurology , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Ludwig Kappos Et Al. }, title={The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study}, congress name={60th Annual Meeting of the American-Academy-of-Neurology}, city={Illinois}, country={United States Of America}, year={2008}}